Page 2 - Benchmark Electronics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Loughborough, England, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today released its financial results for the quarter ended June 30, 2023 and provided a business update. Corporate Highlights: Previously announced initial patient data from UK NHS (National Health Servic

Operator: Good day, and welcome to Benchmark Electronics Inc. Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions].

Loughborough, England, July 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company...

The electronic contract assembly market incremental growth recorded during (2023-2028) is $97.67 Billion. The shift toward electric vehicles (EVs) is...

The enzyme contract manufacturing market dynamics are anticipated to change in the coming years owing to the burgeoning...